Dr James Donahue

Piper Jaffray released a research report on Forest Laboratories (NASDAQ: FRX) announcing there is mixed feedback on Daliresp from a physician expert. In the report, Piper Jaffray writes, “We hosted a call with Dr. James Donohue, a thought leader in chronic obstructive pulmonary disease (COPD) and...